For CNS autoimmune syndromes, well-validated disease-specific fluid biomarkers already guide diagnosis and management: serum and CSF anti-AQP4 and anti-MOG autoantibodies are clinically established for discriminating neuromyelitis optica spectrum disorder (NMOSD), MOG-antibody disease and MS-like presentations, and serial antibody titers sometimes correlate with relapse risk and radiological activity (152, 153)
Iron and ferroptosis in kidney disease: molecular and metabolic mechanisms
Severe Brain Fog and Cognitive Impairment: Neuroinflammation is heavily driven by localized oxidative stress and a lack of antioxidant protection in the brain
When to See a Specialist While supplements can help, theyre not a substitute for medical evaluation
European Review for Medical and Pharmacological Sciences, 23 (12), 5512-5521
GLP-1 adoption is the kind of change those engines were never calibrated for